Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma
This study is ongoing, but not recruiting participants.
Study NCT00115739   Information provided by University of Michigan Cancer Center
First Received: June 23, 2005   Last Updated: May 6, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Thyroid Cancer
Additional conditions recognized in this trial
Thyroid Neoplasms
More general conditions related to this trial
Endocrine Gland Neoplasms
Endocrine System Diseases
Head and Neck Neoplasms
Neoplasms
Neoplasms by Site
Thyroid Diseases
Interventions listed in this trial
Imatinib (Gleevec)
Additional drug interventions recognized in this trial
Imatinib
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
University of Michigan Cancer Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services